Identification of a pharmacogenetic effect by linkage disequilibrium mapping

Pharmacogenomics Journal

Volumn 4, Issue 6, 2004, Pages 374-378

  Xu, C F ^a   Lewis, K F ^a   Yeo, A J ^a   McCarthy, L C ^a   Maguire, M F ^a   Anwar, Z ^a   Danoff, T M ^b   Roses, A D ^b   Purvis, I J ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

^b GLAXOSMITHKLINE   (United States)

Author keywords

Hyperbilirubinemia; Linkage disequilibrium; Pharmacogenetics; Tranilast; UGT1A1

Indexed keywords

GLUCURONOSYLTRANSFERASE; TRANILAST;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DNA FLANKING REGION; GENE LINKAGE DISEQUILIBRIUM; GENE MAPPING; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOME ANALYSIS; GILBERT DISEASE; HUMAN; HYPERBILIRUBINEMIA; MAJOR CLINICAL STUDY; PHARMACOGENETICS; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ANTHRANILIC ACIDS; CLINICAL TRIALS, PHASE III; GLUCURONOSYLTRANSFERASE; HUMANS; LINKAGE DISEQUILIBRIUM; PHARMACOGENETICS; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 9644287589     PISSN: 1470269X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.tpj.6500268     Document Type: Article

References (25)

1. Carlson CS, Newman TL, Nickerson DA. SNPing in the human genome. Curr Opin Chem Biol 2001; 5: 78-85.
2. Dawson E, Abecasis GR, Bumpstead S, Chen Y, Hunt S, Beare DM et al. A first-generation linkage disequilibrium map of human chromosome 22. Nature 2002; 418: 544-548.
3. Kruglyak L. Prospects for whole-genome linkage disequilibrium mapping of common disease genes. Nat Genet 1999; 22: 139-144.
4. Lai E, Bowman C, Bansal A, Hughes A, Mosteller M, Roses AD. Medical applications of haplotype-based SNP maps: learning to walk before we run. Nat Genet 2002; 32: 353.
5. Goldstein DB, Ahmadi KR, Weale ME, Wood NW. Genome scans and candidate gene approaches in the study of common diseases and variable drug responses. Trends Genet 2003; 19: 615-622.
6. Lai E, Riley J, Purvis I, Roses A. A 4-Mb high-density single nucleotide polymorphism-based map around human APOE. Genomics 1998; 54: 31-38.
7. Phillips MS, Lawrence R, Sachidanandam R, Morris AP, Balding DJ, Donaldson MA et al. Chromosome-wide distribution of haplotype blocks and the role of recombination hot spots. Nat Genet 2003; 33: 382-387.
8. Couzin J. Human genome. HapMap launched with pledges of $100 million. Science 2002; 298: 941-942.
9. Cardon LR, Abecasis GR. Using haplotype blocks to map human complex trait loci. Trends Genet 2003; 19: 135-140.
10. Danoff TM, Campbell DA, McCarthy LC, Lewis KF, Repasch MH, Saunders AM et al. A Gilbert's syndrome UGT1A1 variant confers susceptibility to tranilast-induced hyperbilirubinemia. Pharmacogenomics J 2004; 4: 49-53.
11. Holmes Jr DR, Savage M, LaBlanche JM, Grip L, Serruys PW, Fitzgerald P et al. Results of Prevention of REStenosis with Tranilast and its Outcomes (PRESTO) trial. Circulation 2002; 106 1243-1250.
12. Roses AD. Genome-based pharmacogenetics and the pharmaceutical industry. Nat Rev 2002; Drug Discov. 1: 541-549.
13. Hetherington S, Hughes AR, Mosteller M, Shortino D, Baker KL, Spreen W et al. Genetic variations in HLA-B region and hypersensitivity reactions to abacavir. Lancet 2002; 359: 1121-1122.
14. Arranz MJ, Collier DA, Munro J, Sham P, Kirov G, Sodhi M et al. Analysis of a structural polymorphism in the 5-HT2A receptor and clinical response to clozapine. Neurosci Lett 1996; 217: 177-178.
15. Goldstein DB, Tate SK, Sisodiya SM. Pharmacogenetics goes genomic. Nat Rev Genet 2003; 4: 937-947.
16. Masellis M, Basile V, Meltzer HY, Lieberman JA, Sevy S, Macciardi FM et al. Serotonin subtype 2 receptor genes and clinical response to clozapine in schizophrenia patients. Neuropsychopharmocology 1998; 19: 123-132.
17. Murphy Jr GM, Kremer C, Rodrigues HE, Schatzberg AF. Pharmacogenetics of antidepressant medication intolerance. Am J Psychiatry 2003; 160: 1830-1835.
18. Meng Z, Zaykin DV, Xu CF, Wagner M, Ehm MG. Selection of genetic markers for association analyses, using linkage disequilibrium and haplotypes. Am J Hum Genet 2003; 73: 115-130.
19. Schork NJ, Nath SK, Fallin D, Chakravarti A. Linkage disequilibrium analysis of biallelic DNA markers, human quantitative trait loci, and threshold-defined case and control subjects. Am J Hum Genet 2000; 67: 1208-1218.
20. Bowman C, Classification Using SNP Profiles Royal Statistical Society: Leuven, Belgium 2003; Statistical Genetics and Bioinformatics, July 14-17.
21. Holmes D, Fitzgerald P, Goldberg S, LaBlanche J, Lincoff AM, Savage M et al. The PRESTO (Prevention of restenosis with tranilast and its outcomes) protocol: a double-blind, placebo-controlled trial. Am Heart J 2000; 139: 23-31.
22. SAS. SAS Release 8. SAS Institute: Cary, NC 2000.
23. Mehta C, Patel N. A network algorithm for performing Fisher's exact test in r × c contingency tables. J Am Stat Assoc 1983; 78: 427-434.
24. Lewontin R. The interaction of selection and linkage. I. General considerations; heterotic models. Genetics 1964; 49: 49-67.
25. Weir BS. Disequilibrium. Genetic Data Analysis II. Sinauer Associates Inc.: Sunderland, MA 1996: 137.